-
Eunice S. Wang, MD; Roswell Park Comprehensive Cancer Institute; 5Live #ASH20
9:52
Key insights from the 2020 Annual Hematology meeting in Leukemia
-
07 - ANA ALFONSO, MD, PhD, Nathan Fowler, MD #Micro2019
4:34
Recap: Transforming Therapy in Blood Cancers presented at the 7th Annual Translational Workshop on Hematologic Malignancies.
-
Hagop Kantarjian, MD #SOHO2019
23:11
Presentation on AML: Selecting Therapy for Newly Diagnosed Patients presented at the 2019 SOHO Conference.
-
AML Hotline: Treatment Approaches for Acute Myeloid Leukemia
50:31
-
AML Hotline: Diagnostic Evaluation and Risk Stratification
51:21
-
Alexander Perl, MD, Harry Erba, MD, PhD #p2p2019
12:26
Podium to Practice: Targeting BCL-2-MP4 Recent Updates to the Therapeutic Landscape of Acute Myeloid Leukemia
-
Daniel DeAngelo, MD, PhD #Micro2018
2:34
The arrival of immunotherapy in the acute leukemia therapeutic landscape presented at the 6th Annual Translational Summit on the Immune Microenvironment.
ABOUT
Bio Ascend is an independent medical education company committed to supporting healthcare providers in their efforts to translate innovative science into clinical practice.
The Bio Ascend team has deep oncology and hematology expertise with a proven ability to distill complex scientific ideas into their essential components, as well as extensive experience in planning, executing, and assessing meaningful education for clinicians.
CONNECT
© Copyright 2021 Bio Ascend, a Vaniam Group company